Salute e Benessere

BerGenBio Appoints Olav Hellebø as CEO

"BerGenBio is at the forefront of exploring highly selective AXL inhibition as a therapeutic enhancement for the large number of patients with non-squamous non-small cell lung cancer with mutations in the STK11 gene. I am thrilled to join the company and look forward to collaborating with the board and team to advance the candidate drug, bemcentinib, through the next stages of clinical development and to take BerGenBio to the next phase", said Olav Hellebø. "BerGenBio is at the…
PR Newswire
20/11/2024

GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for…

"Adding automated aseptic fill-finish capabilities to our service offerings strengthens our ability to meet the diverse requirements of our clients, from start-up biotech to established pharmaceutical companies," said Karl Pinto, & CEO at GBI. "Our facility is equipped with state-of-the-art technology and a team of experts, capable of delivering high-quality, regulatory compliant drug products." "Adding automatedaseptic fill-finishcapabilities to our service…
PR Newswire
20/11/2024

The Gene Revolution: Transforming Lives through Gene Editing Therapeutics

This report takes a close look at the current and future possibilities of gene editing treatments and explores the factors that will help or hinder their use. It also examines the competitive landscape, including what therapeutics companies are working on and how they plan to bring new treatments to market. Additionally, it predicts how the market will evolve by 2029 and provides in-depth profiles of key players, including their business focus, financials, and products. This report takes a...
PR Newswire
20/11/2024

Plentiful Launches Digital Marketplace to Meet Rising Demand for Accessible…

Plentiful partners with a diverse range of practitioners including life and career coaches, nutrition and fitness specialists, relationship and parenting experts, and guides across many other wellness categories. Each practitioner offers experiences designed to help individuals or teams stop feeling stuck and reach their full potential. Plentiful partners with a diverse range of practitioners including life and career coaches, nutrition and fitness specialists, relationship and parenting...
PR Newswire
20/11/2024

Guidewires Market to Reach USD 1663.5 Million by 2030: Key Trends in Angled…

Claim Your Free Report: Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-28W15599/Global_and_India_Guide_Wires_Market Major Factors Driving the Growth of Guidewires Market: The guidewire market is growing rapidly due to rising demand for minimally invasive procedures and the increasing prevalence of chronic diseases. Key factors driving the market include advancements in guidewire technology, expanding healthcare infrastructure in emerging regions,...
PR Newswire
20/11/2024

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.Please read the full announcement in PDF. Attachment 2024_47_Trading_By_Management
Nasdaq GlobeNewswire
20/11/2024

AI's Growing Role in Transforming Healthcare Delivers Innovations in…

The article continued: Analysts at MarketsandMarkets Research forecast the AI in Healthcare Market to expand at a remarkable 48.1% CAGR, reaching $148.4 billion by 2029. With billions in investment pouring in, the World Economic Forum emphasizes the need for strategic spending, workforce adaptation, and proactive preparation to ensure these innovations achieve their full potential in reshaping global healthcare. The article continued: Analysts atMarketsandMarkets Researchforecast theAI in...
PR Newswire
20/11/2024

KOELIS announces the first interim results of the VIOLETTE trial which evaluates…

Recent advances in imaging technology have helped reduce the overdiagnosis and overtreatment of prostate cancer. The use of prostate MRI prior to the so-called “fusion” biopsy guided by MRI/ultrasound fusion imaging has proven its ability to visualize and accurately describe cancerous lesions on the way to a more personalized treatment.Thanks to the Koelis Trinity® fusion imaging system, a platform based on a disruptive technology called Organ-Based Tracking ®(OBT-Fusion), which...
Nasdaq GlobeNewswire
20/11/2024

COP29: Pricing gap means fashion remains amongst largest polluters globally -…

Fashion's high environmental impact has wide-reaching effects on climate, water and ecosystems. Its problems stem from multiple factors, particularly high costs and affordability. Fashion's high environmental impact has wide-reaching effects on climate, water and ecosystems. Its problems stem from multiple factors, particularly high costs and affordability. Marguerite Le Rolland, head of footwear and apparel at Euromonitor International, said:"Sustainable fashion requires investing in...
PR Newswire
20/11/2024

John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and…

Elway will speak to several media outlets on November 20, 2024 to detail his patient journey and provide an update on his current hand health. He believes he is feeling the beginning of Dupuytren's contracture in another finger, and he plans to request treatment with XIAFLEX again. Elway will speak to several media outlets onNovember 20, 2024to detail his patient journey and provide an update on his current hand health. He believes he is feeling the beginning of Dupuytren's contracture in...
PR Newswire
20/11/2024

The commercialization of Bioretec's RemeOs™ Trauma Screw in the U.S. proceeds…

"The initial controlled launch of RemeOs™ Trauma Screws in the U.S. yielded excellent patient results, with a notable number of surgeries and successful post-healing follow-ups. This success lays the groundwork for entering the second phase of commercialization for RemeOs™ products in the U.S. and driving strong demand within the surgeon community. This agreement evidences our commitment to the RemeOs™ Trauma Product line, its commercialization, and the strengthening of distribution…
PR Newswire
20/11/2024

UNAVETS founder appointed as Senior Advisor to Oaktree Capital Management

Junko Sheehan said: "UNAVETS started five years ago with nothing but a business plan and a value proposition for the vet sector. Making that transformation from idea into concrete execution with a terrific team of committed, passionate people is what has made this journey so special. As a Senior Advisor to Oaktree, I will still be deeply involved in the strategic direction of the company alongside my partners, Oaktree, and this will afford me some time to dedicate to other consolidation and…
PR Newswire
20/11/2024

Sanofi: Information concerning the total number of voting rights and shares -…

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,537,214,304 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the...
Nasdaq GlobeNewswire
20/11/2024

DermRays Amazon Black Friday Event Offers Best Deals of the Year

The DermRays V6S has redefined at-home laser hair removal, especially for users with darker skin tones, a market where safe and effective options are limited. Leveraging 1064nm laser technology-widely recognized as the gold standard in professional aesthetics. DermRays provides an effective solution with the precision of salon-grade technology in the comfort of home. This advanced laser ensures safer, more effective hair reduction for a broad range of skin tones, setting it apart as the only…
PR Newswire
20/11/2024

Perceptive Imaging Improves Oncology Trial Outcomes through Enhanced Services

There is growing concern about the amount of variability in radiotherapy treatments among investigative sites and its potential impact on pharmaceutical efficacy and toxicity evaluations. This presents a need to centrally evaluate the conformance of radiotherapy plans to the treatment guidelines for a given protocol. There is growing concern about the amount of variability in radiotherapy treatments among investigative sites and its potential impact on pharmaceutical efficacy and toxicity…
PR Newswire
20/11/2024

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset

About Acurx Pharmaceuticals, Inc. About Acurx Pharmaceuticals, Inc. Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. The Company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to...
PR Newswire
20/11/2024

Recursion and Exscientia, two leaders in the AI drug discovery space, have…

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discoveryRecursion will host an update call today, November 20, 2024 at 7:30 a.m. ET / 5:30 a.m. MT / 12:30 p.m. GMT on LinkedIn, X and...
Nasdaq GlobeNewswire
20/11/2024

Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC…

Avextra Portugal launches an innovative in-house breeding program to develop proprietary cannabis varieties with specific, consistent and reproducible cannabinoid and terpene profiles. Over a two-year period, a total of 5,000 seeds will be used for a comprehensive phenohunt of the Avextra cultivar. So far, 600 seeds have been utilised in the process.Led by industry experts, including former GW Pharmaceuticals Director Alan Sutton and genetics and cultivation expert Steven Tan, the...
Nasdaq GlobeNewswire
20/11/2024

BIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION…

Recently, large-scale shipments were made by SpayVac for Wildlife to support a major feral horse population management project in Europe, underscoring their commitment to expanding animal population control efforts globally. This follows the production of vaccine for an immunocontraception project in Southeast Asia this past summer. Recently, large-scale shipments were made by SpayVac for Wildlife to support a major feral horse population management project inEurope, underscoring their...
PR Newswire
20/11/2024

Casino Group: Agreement for Trinity to transfer its shares in France Retail…

Agreement for Trinity to transfer its sharesin France Retail Holdings to EPEI III Paris, 20 November 2024Casino, Guichard-Perrachon (« Casino ») announces that it has been informed on 19 November 2024 of the signing of a share purchase agreement by which Trinity Investments Designated Activity Company, whose management company is Attestor Limited («Trinity») is to transfer to EP Equity Investment III S.à r.l. (« EPEI ») 1its 7.65% shareholding in France Retail Holdings S.à.r...
Nasdaq GlobeNewswire
20/11/2024

The Lazarus Practice: Ex Goldman Sachs and Headspace Leaders Pioneer a New Era…

The practice is spearheaded by visionary founders Dr Ian Dodd, a former Goldman Sachs executive who experienced a severe burnout and depression, and Dr David Cox, ex-Chief Medical Officer at Headspace. It emerges from a critical need to overcome the widespread failures of the majority of private and public mental health services. The practice is spearheaded by visionary founders DrIan Dodd, a former Goldman Sachs executive who experienced a severe burnout and depression, and DrDavid Cox,...
PR Newswire
20/11/2024

Press Release: Sequana Medical announces Extraordinary General Meeting of…

Sequana Medical announces Extraordinary General Meeting of Shareholderson 20 December 2024Ghent, Belgium – 20 November 2024– Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Extraordinary General Meeting of Shareholders on Friday, 20 December 2024.The items on the agenda of…
Nasdaq GlobeNewswire
20/11/2024

AmacaThera Announces Phase 1 Results of First-in-Human Study with AMT-143…

The recent clinical data has strengthened support for AmacaThera with lead investor of AmacaThera's recently completed Series A extension Paul Austin saying "The progress shown in the Phase 1 study demonstrates the tremendous potential of AMT-143 to transform post-operative pain management. Based on these strong results, we are increasing our investment to accelerate its continuing development." The recent clinical data has strengthened support for AmacaThera with lead investor of…
PR Newswire
20/11/2024

Custom T-shirt Printing Market: Projected to Grow at a 7.20% CAGR, Reaching USD…

The Custom T-shirt Printing Market is set to grow from USD 9.23 billion in 2023 to USD 17.27 billion by 2032, at a 7.20% CAGR. Growth is driven by rising demand for personalized apparel, advancements in printing technologies, and increased adoption for promotional and corporate purposes. The e-commerce boom and eco-friendly printing practices further fuel market expansion, with North America and Asia-Pacific leading the growth. TheCustom T-shirt Printing Marketis set to grow fromUSD 9...
PR Newswire
20/11/2024
Altri  Comunicati